Patients with hypokalemia should closely monitor their blood potassium levels when receiving intravenous potassium supplementation, rechecking potassium levels within 1-4 hours after supplementation. Continuous electrocardiogram monitoring is necessary to closely observe any changes in the electrocardiogram and prevent life-threatening hyperkalemia. In patients with renal impairment, the potassium supplementation should be 50% of that for normal patients, and it is generally considered that the daily potassium supplementation should not exceed 100-200 mmol. For patients with severe hypokalemia, the total daily potassium supplementation can reach 240-400 mmol, but blood potassium levels should be closely monitored to prevent hyperkalemia. Peripheral administration of high-concentration potassium can irritate the vein wall, causing pain and phlebitis. Generally, it is considered that the rate of potassium supplementation through peripheral veins should not exceed 40 mmol/L.